Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Effector Raises $38.6M to Advance New Class of Anti-Cancer Drugs
Effector Raises $38.6M to Advance New Class of Anti-Cancer Drugs
Effector Raises $38.6M to Advance New Class of Anti-Cancer Drugs
Submitted by
admin
on July 25, 2017 - 8:28am
Source:
Xconomy
News Tags:
Effector
small molecule drugs
venture capital
Headline:
Effector Raises $38.6M to Advance New Class of Anti-Cancer Drugs
Do Not Allow Advertisers to Use My Personal information
